Biomarkers associated with regorafenib first-line treatment benefits in metastatic colorectal cancer patients: Reframe molecular study

  1. Conde, E.
  2. Earl, J.
  3. Crespo-Toro, L.
  4. Blanco-Agudo, C.
  5. Ramos-Muñoz, E.
  6. Rodríguez-Serrano, E.M.
  7. Martínez Ávila, J.C.
  8. Salinas-Muñoz, L.
  9. Serrano-Huertas, S.
  10. Ferreiro, R.
  11. Rodriguez-Garrote, M.
  12. Sainz, B.
  13. Massuti, B.
  14. García Alfonso, P.
  15. Benavides, M.
  16. Aranda, E.
  17. García-Bermejo, M.L.
  18. Carrato, A.
Aldizkaria:
Cancers

ISSN: 2072-6694

Argitalpen urtea: 2021

Alea: 13

Zenbakia: 7

Mota: Artikulua

DOI: 10.3390/CANCERS13071710 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus